FDA Inspection 1305486 - GlaxoSmithKline Biologicals SA - February 27, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns GlaxoSmithKline Biologicals SA, with an inspection on February 27, 2026, issued by the Office of Inspections and Investigations, covering biologics.

Company: GlaxoSmithKline Biologicals SA
Inspection Date: February 27, 2026
Product Type: Biologics
Office: Office of Inspections and Investigations

Open in Dashboard

ID · a73f4473-48f2-4d60-ada1-1284eeb61f46

Violation Codes5

21 CFR 211.100(a)21 CFR 211.100(b)21 CFR 211.113(b)21 CFR 211.42(c)(10)(iv)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.